Replimune

Funding reported, $150M, last update 6 days ago

Pharma biotech · Headquarters United States

Everything we hold on Replimune, newest first. Every line links to the filing or report it came from.

This profile is thin because we hold one source document on Replimune so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

1. 2026-08-10
   Headcount Not Stated Growing and expanding

   Replimune bondit après une levée de fonds de 150 millions de dollars pour un médicament contre le cancer de la

   Replimune raised $150M for cancer-drug development in the US. The announcement does not disclose hiring plans; watch its careers page for biotech roles.

   France · $150M raised · News Report · Boursorama · archived copy

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker